As of Oct 20
| -0.21 / -2.04%|
The 6 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 24.00, with a high estimate of 29.00 and a low estimate of 19.00. The median estimate represents a +138.10% increase from the last price of 10.08.
The current consensus among 6 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.